PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

COVID-19 vaccination and boosting during pregnancy protects infants for six months

COVID-19 vaccination and boosting during pregnancy protects infants for six months
2024-02-14
(Press-News.org) WHAT:
Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic COVID-19 infection for at least six months after birth, according to a study from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. These findings, published in Pediatrics, reinforce the importance of receiving both a COVID-19 vaccine and booster during pregnancy to ensure that infants are born with robust protection that lasts until they are old enough to be vaccinated.

COVID-19 is especially dangerous for newborns and young infants, and even healthy infants are vulnerable to COVID-19 and are at risk for severe disease. No COVID-19 vaccines currently are available for infants under six months old. Earlier results from the Multisite Observational Maternal and Infant COVID-19 Vaccine (MOMI-Vax) study revealed that when pregnant volunteers received both doses of an mRNA COVID-19 vaccine, antibodies induced by the vaccine could be found in their newborns’ cord blood. This suggested that the infants likely had some protection against COVID-19 when they were still too young to receive a vaccine. However, researchers at the NIAID-funded Infectious Diseases Clinical Research Consortium (IDCRC), which conducted the study, did not know how long these antibody levels would last or how well the infants would actually be protected. The research team hoped to gather this information by following the infants through their first six months of life.

In this portion of the study, researchers analyzed data from 475 infants born while their pregnant mothers were enrolled in the MOMI-Vax study. The study took place at nine sites across the United States. It included 271 infants whose mothers had received two doses of an mRNA COVID-19 vaccine during pregnancy. The remaining 204 infants in the study were born to mothers who had received both doses of an mRNA COVID-19 vaccine as well as a COVID-19 booster. To supplement data gathered during pregnancy and at birth, the infants were evaluated during at least one follow-up visit during their first six months after birth. Parents also reported whether their infants had become infected or had demonstrated COVID-19 symptoms.

Based on blood samples from the infants, the researchers found that newborns with high antibody levels at birth also had greater protection from COVID-19 infection during their first six months. While infants of mothers who received two COVID-19 vaccine doses had a robust antibody response at birth, infants whose mothers had received an additional booster dose during pregnancy had both higher levels of antibodies at birth and greater protection from COVID-19 infection at their follow-up visits.

While older children and adults should continue to follow guidance from the Centers for Disease Control and Prevention (CDC) to stay up-to-date on their COVID-19 vaccines and boosters, this study highlights how much maternal vaccination can benefit newborns too young to take advantage of the vaccine: During the course of this study, none of the infants examined required hospitalization for COVID-19. Researchers will continue to evaluate the data from the MOMI-Vax study for further insights concerning COVID-19 protection in infants.

ARTICLE:
CV Cardemil et al. Maternal COVID-19 Vaccination and Prevention of Symptomatic Infection in Infants. Pediatrics DOI: 10.1542/peds.2023-064252 (2024).

WHO:
Cristina Cardemil, M.D., a medical officer in NIAID’s Division of Microbiology and Infectious Diseases, is available to comment.

CONTACT:
To schedule interviews, please contact Elizabeth Deatrick, (301) 402-1663, NIAIDNews@niaid.nih.gov.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit https://www.nih.gov/. 

NIH...Turning Discovery Into Health®

END


[Attachments] See images for this press release:
COVID-19 vaccination and boosting during pregnancy protects infants for six months COVID-19 vaccination and boosting during pregnancy protects infants for six months 2 COVID-19 vaccination and boosting during pregnancy protects infants for six months 3

ELSE PRESS RELEASES FROM THIS DATE:

Love songs lead scientists to new populations of skywalker gibbons in Myanmar

Love songs lead scientists to new populations of skywalker gibbons in Myanmar
2024-02-14
Skywalker gibbon couples wake up each morning and sing to each other, their voices echoing across the forest canopy of their home. The primate’s endearing love song helped scientists confirm what was formerly a strong hunch: Myanmar has the largest population of endangered Skywalker gibbons on Earth. When Star Wars-loving scientists identified Skywalker gibbons as a distinct species in 2017, fewer than 200 individuals were known to exist, all in southwestern China. A study published today in the International Journal of Primatology is the first in the past century to confirm living Skywalker gibbons in ...

Case study: drug-resistant bacteria responds to phage-antibiotic combo therapy

Case study: drug-resistant bacteria responds to phage-antibiotic combo therapy
2024-02-14
PITTSBURGH, Feb. 14, 2024 – It was a last-ditch effort. For years doctors had tried to keep a patient’s recurrent drug-resistant bacterial blood infection at bay, but it kept coming back and antibiotics were no longer working. The family agreed to try an experimental treatment that uses viruses to kill bacteria. The patient’s Enterococcus faecium bacterial strain, which had become zombie-like and was almost impossible to treat with currently available antibiotics, was tested against wastewater collected from across the country to find a virus – called a bacteriophage – that scientists theorized would specifically target the drug-resistant bacteria. It worked ...

ETRI unveils AI analysis service platform at international e-sports tournament

ETRI unveils AI analysis service platform at international e-sports tournament
2024-02-14
ETRI’s researchers have developed an AI-powered e-sports analysis platform that provides real-time win rate prediction services by analyzing gameplay screens. This platform was notably applied to the highly popular League of Legends (LoL) during a recent international e-sports tournament, garnering positive feedback. Electronics and Telecommunications Research Institute (ETRI) has developed a technology that recognizes real-time game situations by analyzing play elements extracted from game videos and automatically generates highlights by identifying key play events in the game. Also, this e-sports service platform, based ...

Pancreatic cancer hijacks a brain-building protein

Pancreatic cancer hijacks a brain-building protein
2024-02-14
Scientists at Cold Spring Harbor Laboratory (CSHL) and the University of California, Davis have reached a new breakthrough in pancreatic cancer research—eight years in the making. It could help slow the disease’s deadly spread. In 2017, as a postdoc in CSHL’s Tuveson lab, Chang-il Hwang and collaborators from the Vakoc lab uncovered a protein essential for jumpstarting metastasis in pancreatic ductal adenocarcinoma (PDAC). Now an assistant professor at UC Davis, Hwang recently reunited with CSHL Professors David Tuveson and Christopher Vakoc. The trio once again set their sights on PDAC. The disease is known for its aggressiveness. ...

Pesticides to help protect seeds can adversely affect earthworms’ health

Pesticides to help protect seeds can adversely affect earthworms’ health
2024-02-14
While pesticides protect crops from hungry animals, pesky insects, or even microbial infections, they also impact other vital organisms, including bees and earthworms. And today, research published in ACS’ Environmental Science & Technology Letters reveals that worms are affected by the relatively small amounts of chemicals that can leach out of pesticide-treated seeds. Exposure to nonlethal amounts of these insecticides and fungicides resulted in poor weight gain and mitochondrial DNA (mtDNA) damage in the worms. Pesticide treatment can be introduced at several different ...

Discovery of a subset of human short introns that are spliced out by a novel mechanism

Discovery of a subset of human short introns that are spliced out by a novel mechanism
2024-02-14
In humans, the length of pre-mRNA varies extensively (from 30 to 1,160,411 nucleotides by recent studies). The fundamental mechanism of splicing has been studied with model pre-mRNAs including 158- and 231-nt introns, for historical instance, that are spliced very efficiently in vitro and in vivo. Such an ideal pre-mRNA contains good splicing signal sequences, i.e., the 5′ splice site, the branch-site (BS) sequence, and the polypyrimidine tract (PPT) followed by the 3′ splice site that are recognized by U1 snRNP, U2 snRNP and U2AF2–U2AF1, respectively. Prof. Mayeda says, “Given the diverse lengths ...

Cold-water coral traps itself on mountains in the deep sea

Cold-water coral traps itself on mountains in the deep sea
2024-02-14
Corals searching for food in the cold and dark waters of the deep sea are building higher and higher mountains to get closer to the source of their food. But in doing so, they may find themselves trapped when the climate changes. That is shown in the thesis that theoretical ecologist Anna van der Kaaden of NIOZ in Yerseke and the Copernicus Institute for Sustainable Development in Utrecht will defend on Feb. 20 at the University of Groningen. “When the water gets warmer, these creatures prefer to be deeper, but a coral doesn’t just walk down the mountain,” Van der Kaaden said. Deep and dark Unlike the famous, colorful tropical corals, cold-water corals live ...

Cost-effective to routinely change surgical gloves and instruments as well as being safer

2024-02-14
Surgeons who routinely change surgical gloves and instruments are incurring similar costs to those using the same equipment, a new study has found. The economic evaluation funded by the UK’s National Institute for Health and Care Research (NIHR) follows a clinical trial conducted at 80 hospitals in Benin, Ghana, India, Mexico, Nigeria, Rwanda, and South Africa which established that routine change of gloves and instruments reduces surgical site infections (SSIs) by 13%. The evaluation, published by the Lancet Global ...

Scientists discover hidden army of lung flu fighters

Scientists discover hidden army of lung flu fighters
2024-02-14
Scientists have long thought of the fluid-filled sac around our lungs merely as a cushion from external damage. Turns out, it also houses potent virus-eating cells that rush into the lungs during flu infections. Not to be confused with phages, which are viruses that infect bacteria, these cells are macrophages, immune cells produced in the body.  “The name macrophage means ‘big eater.’ They gobble up bacteria, viruses, cancer cells, and dying cells. Really, anything that looks foreign, they take it up and destroy it,” said UC Riverside virologist Juliet Morrison, who led the discovery team. “We were surprised to find them in the lungs ...

USC announces new Leonard D. Schaeffer Institute for Public Policy & Government Service

USC announces new Leonard D. Schaeffer Institute for Public Policy & Government Service
2024-02-14
USC, together with Leonard and his late wife Pamela Schaeffer, is launching a new institute with a $59 million gift from the Schaeffers to be anchored in Los Angeles and in the university’s new Capital Campus in Washington, D.C. The mission of the Leonard D. Schaeffer Institute for Public Policy & Government Service is to strengthen democracy by training generations of public leaders and advancing evidence-based research to shape policy that addresses the nation’s most pressing issues, USC President Carol Folt announced ...

LAST 30 PRESS RELEASES:

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

NTIDE: Disability employment holds steady after data hiatus

Social lives of viruses affect antiviral resistance

Dose of psilocybin, dash of rabies point to treatment for depression

Helping health care providers navigate social, political, and legal barriers to patient care

Barrow Neurological Institute, University of Calgary study urges “major change” to migraine treatment in Emergency Departments

Using smartphones to improve disaster search and rescue

Robust new photocatalyst paves the way for cleaner hydrogen peroxide production and greener chemical manufacturing

Ultrafast material captures toxic PFAS at record speed and capacity

Plant phenolic acids supercharge old antibiotics against multidrug resistant E. coli

UNC-Chapel Hill study shows AI can dramatically speed up digitizing natural history collections

OYE Therapeutics closes $5M convertible note round, advancing toward clinical development

Membrane ‘neighborhood’ helps transporter protein regulate cell signaling

Naval aviator turned NPS doctoral student earns national recognition for applied quantum research

[Press-News.org] COVID-19 vaccination and boosting during pregnancy protects infants for six months